Private equity firm KKR has taken a large stake in Henry Schein and reached a deal to add members to the company's board, the ...

Jefferies analyst Glen Santangelo assigned a Hold rating to Henry Schein (HSIC – Research Report) today and set a price target of $80.00. The ...

Evercore ISI analyst Elizabeth Anderson CFA maintained a Hold rating on Henry Schein (HSIC – Research ... branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests ...

This was the stock's fourth consecutive day of losses.

Private equity firm KKR increased its stake in Henry Schein Inc., investing $250 million in the company to help boost financial performance, according to the Melville-based company. The investment ...

Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Henry Schein HSIC in the last three months. The table below offers a condensed view of their ...

NORTHFIELD, Minn., Feb. 4, 2025 /PRNewswire/ -- Aurora Pharmaceutical, a leader in animal health solutions, is proud to announce a 30% expansion of its sales force over the past three years.

Allan rounded out his career working for Schein Pharmaceutical Inc. as VP and General Manager for Marasam Pharmaceuticals in Cherry Hill, NJ. Allan and Carol lived very active pre-and-post ...